Home/Filings/4/0001209191-21-067275
4//SEC Filing

Conte Kelley 4

Accession 0001209191-21-067275

CIK 0001145986other

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 4:36 PM ET

Size

15.9 KB

Accession

0001209191-21-067275

Insider Transaction Report

Form 4
Period: 2021-11-30
Conte Kelley
Vice President,Human Resources
Transactions
  • Sale

    Common Stock

    2021-11-30$58.09/sh2,358$136,97662,097 total
  • Exercise/Conversion

    Common Stock

    2021-11-30$5.82/sh+20,000$116,40082,097 total
  • Exercise/Conversion

    Stock Option (Right-to-Buy)

    2021-11-3020,0004,609 total
    Exercise: $5.82Exp: 2025-11-11Common Stock (20,000 underlying)
  • Sale

    Common Stock

    2021-11-30$54.95/sh8,013$440,31474,084 total
  • Sale

    Common Stock

    2021-11-30$55.83/sh5,126$286,18568,958 total
  • Sale

    Common Stock

    2021-11-30$57.04/sh4,503$256,85164,455 total
Footnotes (10)
  • [F1]Represents 63,493 shares of Common Stock and 18,604 Restricted Stock Units.
  • [F10]These options are fully vested and exercisable.
  • [F2]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $54.34 to $55.34 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  • [F3]Represents 55,480 shares of Common Stock and 18,604 Restricted Stock Units.
  • [F4]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $55.40 to $56.29 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  • [F5]Represents 50,354 shares of Common Stock and 18,604 Restricted Stock Units.
  • [F6]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $56.48 to $57.48 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  • [F7]Represents 45,851 shares of Common Stock and 18,604 Restricted Stock Units.
  • [F8]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $57.50 to $58.49 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  • [F9]Represents 43,493 shares of Common Stock and 18,604 Restricted Stock Units.

Issuer

ASPEN AEROGELS INC

CIK 0001145986

Entity typeother

Related Parties

1
  • filerCIK 0001668364

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:36 PM ET
Size
15.9 KB